₹14.20
(Market cap
₹4,549 Cr
Recently Viewed
Clear AllMarket cap
₹4,549 Cr
Revenue (TTM)
₹473 Cr
P/E Ratio
--
P/B Ratio
6.1
Div. Yield
0.1 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-73 Cr
ROE
-36.2 %
ROCE
-28.1 %
Industry P/E
49.8
EV/EBITDA
259.5
Debt to Equity
0
Book Value
₹214.2
EPS
₹-23.3
Face value
10
Shares outstanding
34,632,587
CFO
₹-39.72 Cr
EBITDA
₹65.84 Cr
Net Profit
₹-41.95 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zota Health Care
| -15.0 | 19.7 | 9.5 | 48.5 | 66.8 | 52.1 | -- |
|
BSE Healthcare
| 0.1 | 2.8 | 5.2 | 3.6 | 24.0 | 13.2 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zota Health Care
| 93.8 | 66.7 | 55.6 | -23.2 | 122.1 | -5.3 | 2.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zota Health Care
|
1,313.5 | 4,549.0 | 472.8 | -72.5 | -12.2 | -26.9 | -- | 6.1 |
| 2,423.2 | 19,833.3 | 1,215.1 | 284.8 | 28.7 | 21.1 | 69.1 | 13.0 | |
| 764.6 | 15,021.4 | 7,266.8 | 627.5 | 11.9 | 12.6 | 23.9 | 2.8 | |
| 362.9 | 13,894.8 | 2,051.5 | 180.5 | 11.6 | 7.7 | 68.9 | 3.6 | |
| 672.8 | 16,680.5 | 5,092.5 | 545.5 | 15.9 | 14.1 | 30.6 | 3.8 | |
| 1,071.0 | 19,182.7 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.3 | 2.2 | |
| 1,611.0 | 18,467.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 918.7 | 3.2 | |
| 153.8 | 20,457.1 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.6 | |
| 436.0 | 17,562.1 | 3,720.2 | 352.1 | 13.7 | 8.2 | 49.9 | 3.7 | |
| 1,450.3 | 23,577.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1071.7 | 5.1 |
No Review & Analysis are available.
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical... products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India. Read more
Incorporated
2000
Chairman
Ketankumar Zota
Managing Director
Moxesh Zota
Headquarters
Surat, Gujarat
Website
Looking for more details about Zota Health Care Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Announcements
View Announcements
The share price of Zota Health Care Ltd is ₹1,313.50 (NSE) as of 22-Apr-2026 IST. Zota Health Care Ltd has given a return of 66.84% in the last 3 years.
Since, TTM earnings of Zota Health Care Ltd is negative, P/E ratio is not available.
The P/B ratio of Zota Health Care Ltd is 6.13 times as on 22-Apr-2026, a 85 premium to its peers’ median range of 3.31 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
10.31
|
|
2024
|
0.00
|
13.63
|
|
2023
|
0.00
|
8.82
|
|
2022
|
84.06
|
8.35
|
|
2021
|
0.00
|
5.13
|
The 52-week high and low of Zota Health Care Ltd are Rs 1,740.00 and Rs 801.90 as of 22-Apr-2026.
Zota Health Care Ltd has a market capitalisation of ₹ 4,549 Cr as on 22-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Zota Health Care Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.